Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

59459 1490631916HCLSReviewIrelandMarch2017.pdf
Energy Boardroom

Germany says it is unclear whether Gilead's Sovaldi prevents liver cancer

02.05.2014 / Fierce Pharma

Gilead Sciences has argued that its hep C blockbuster Sovaldi will save healthcare payers money by preventing transplants for patients who develop cancer. But now the U.S. drugmaker has run into the Germany's IQWiG, the toughest among Europe's drug price watchdogs, and it says the evidence for that claim is unclear.

Cover_HCLS_Ireland LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: